Literature DB >> 30911705

Innovations in spinal cord stimulation for pain.

Scott F Lempka1,2,3, Parag G Patil1,2,4,5.   

Abstract

Spinal cord stimulation (SCS) is a neuromodulation therapy used to treat medically refractory chronic pain. In SCS, an implanted pulse generator produces electrical signals that are conveyed through electrode arrays located in the region of the spinal cord. The goal of SCS is to modulate neural signaling through spinal and supraspinal mechanisms to reduce pain. Although available for decades, SCS still enjoys only limited clinical success, limited quality-of-life improvement, and limited long-term efficacy. To improve SCS outcomes, advances in lead design, stimulator features, and waveform paradigms have been recently introduced. While it is an exciting time for the neuromodulation field, empirical SCS advances have surpassed scientific understanding of SCS mechanisms of action. We still do not know why SCS works in some patients but not in others. We also lack information-rich biomarkers of pain and pain relief through which to optimize SCS programming. To optimize both system designs and clinical implementations of SCS, it is critical that we address these scientific and mechanistic knowledge gaps.

Entities:  

Keywords:  Chronic pain; Neuromodulation; Neuropathic pain; Neurostimulation; Spinal cord stimulation

Year:  2018        PMID: 30911705      PMCID: PMC6430588          DOI: 10.1016/j.cobme.2018.10.005

Source DB:  PubMed          Journal:  Curr Opin Biomed Eng        ISSN: 2468-4511


  11 in total

1.  Dorsal root ganglion stimulation for chronic pain modulates Aβ-fiber activity but not C-fiber activity: A computational modeling study.

Authors:  Robert D Graham; Tim M Bruns; Bo Duan; Scott F Lempka
Journal:  Clin Neurophysiol       Date:  2019-03-15       Impact factor: 3.708

2.  Evoked Potentials Recorded From the Spinal Cord During Neurostimulation for Pain: A Computational Modeling Study.

Authors:  Carlos J Anaya; Hans J Zander; Robert D Graham; Vishwanath Sankarasubramanian; Scott F Lempka
Journal:  Neuromodulation       Date:  2019-06-19

Review 3.  Dorsal Root Ganglion Stimulation for Chronic Pain: Hypothesized Mechanisms of Action.

Authors:  Robert D Graham; Vishwanath Sankarasubramanian; Scott F Lempka
Journal:  J Pain       Date:  2021-08-20       Impact factor: 5.820

4.  A computational outlook on neurostimulation.

Authors:  Marco Capogrosso; Scott F Lempka
Journal:  Bioelectron Med       Date:  2020-05-25

Review 5.  A Call to Action Toward Optimizing the Electrical Dose Received by Neural Targets in Spinal Cord Stimulation Therapy for Neuropathic Pain.

Authors:  Krishnan Chakravarthy; Rajiv Reddy; Adnan Al-Kaisy; Thomas Yearwood; Jay Grider
Journal:  J Pain Res       Date:  2021-09-07       Impact factor: 2.832

Review 6.  Burst Spinal Cord Stimulation in the Management of Chronic Pain: Current Perspectives.

Authors:  Amber N Edinoff; Sarah Kaufman; E Saunders Alpaugh; Jesse Lawson; Tucker L Apgar; Farnad Imani; Seyed-Hossein Khademi; Elyse M Cornett; Alan D Kaye
Journal:  Anesth Pain Med       Date:  2022-05-09

7.  Neuromodulation devices for heart failure.

Authors:  Veronica Dusi; Filippo Angelini; Michael R Zile; Gaetano Maria De Ferrari
Journal:  Eur Heart J Suppl       Date:  2022-08-17       Impact factor: 1.624

8.  Somatic inhibition by microscopic magnetic stimulation.

Authors:  Hui Ye; Lauryn Barrett
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

Review 9.  Electrical epidural stimulation of the cervical spinal cord: implications for spinal respiratory neuroplasticity after spinal cord injury.

Authors:  Ian G Malone; Rachel L Nosacka; Marissa A Nash; Kevin J Otto; Erica A Dale
Journal:  J Neurophysiol       Date:  2021-07-07       Impact factor: 2.974

10.  Electronics with shape actuation for minimally invasive spinal cord stimulation.

Authors:  Ben J Woodington; Vincenzo F Curto; Yi-Lin Yu; Héctor Martínez-Domínguez; Lawrence Coles; George G Malliaras; Christopher M Proctor; Damiano G Barone
Journal:  Sci Adv       Date:  2021-06-25       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.